Bellevue Asset Management’s Hims & Hers Health HIMS Stock Holding History

Bellevue Asset Management’s Portfolio HIMS Stock Details HIMS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-95	Closed	-$1.75K	–	501
2024 Q3	$1.75K	Hold	95	–	–	﹤0.01%	429
2024 Q2	$1.92K	Sell	95 -51	-35%	-$849	﹤0.01%	414
2024 Q1	$2.26K	Hold	146	–	–	﹤0.01%	395
2023 Q4	$1.3K	Buy	+146	New	+$1.08K	﹤0.01%	436
2023 Q3	–	Sell	-146	Closed	-$1.37K	–	464
2023 Q2	$1.37K	Hold	146	–	–	﹤0.01%	447
2023 Q1	$1.45K	Buy	+146	New	+$1.28K	﹤0.01%	456
2022 Q1	–	Sell	-179	Closed	-$1K	–	549
2021 Q4	$1K	Sell	179 -14	-7%	-$101	﹤0.01%	543
2021 Q3	$1K	Hold	193	–	–	﹤0.01%	566
2021 Q2	$2K	Buy	193 +35	+22%	+$416	﹤0.01%	522
2021 Q1	$2K	Buy	+158	New	+$2.65K	﹤0.01%	569

Other funds holding HIMS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bellevue Asset Management's HIMS Position: Q4 2024 in Review

Bellevue Asset Management sold out of Hims & Hers Health (HIMS) in Q4 2024, closing a stake of 95 shares — an estimated $1.75K sold.

Bellevue Asset Management first reported a position in HIMS in Q1 2021 and held it in 10 quarters. The position peaked at $2.26K in Q1 2024. 394 funds tracked by Wall St. Rank hold HIMS as of Q4 2024.

Bellevue Asset Management reported no remaining Hims & Hers Health position as of Q4 2024 after selling out during the quarter.
Bellevue Asset Management sold 95 Hims & Hers Health shares in Q4 2024, an estimated $1.75K.
Bellevue Asset Management first reported a position in Hims & Hers Health in Q1 2021 and held it in 10 quarters.
Bellevue Asset Management's Hims & Hers Health position peaked at $2.26K in Q1 2024.
394 funds tracked by Wall St. Rank held Hims & Hers Health as of Q4 2024.

Based on Bellevue Asset Management's 13F filing for Q4 2024, filed 6 Feb 2025.